Department of Breast Surgery, the First Affiliated Hospital, China Medical University, North Nanjing Street 155, Shenyang 110001, P,R, China.
Eur J Med Res. 2014 Mar 13;19(1):14. doi: 10.1186/2047-783X-19-14.
Metaplastic breast carcinoma (MBC) is an uncommon malignancy characterized by the co-existence of two or more cellular types, commonly a mixture of epithelial and mesenchymal components. A case of a female patient aged 46 years with MBC (carcinosarcoma) is presented, including mammographic, ultrasonic, gross examination, and pathological findings. After undergoing modified radical mastectomy of the left breast and subsequent six courses of adjuvant chemotherapy and endocrine therapy, the patient is now doing well with no recurrence and metastasis. Conventional treatments for invasive ductal carcinoma (IDC) may appear to be less effective. Patients with MBC would be appropriate candidates for innovative or targeted therapy regimens.
化生性乳腺癌(MBC)是一种罕见的恶性肿瘤,其特征是两种或更多种细胞类型共存,通常是上皮和间充质成分的混合物。本文报道了 1 例 46 岁女性 MBC(癌肉瘤)患者,包括乳腺 X 线摄影、超声、大体检查和病理检查结果。患者接受了左乳腺癌改良根治术和随后的 6 个周期辅助化疗和内分泌治疗,目前恢复良好,无复发和转移。常规治疗浸润性导管癌(IDC)的方法可能效果不佳。MBC 患者可能适合创新或靶向治疗方案。